Modification of NZB-NZW F1 autoimmune disease by development of tolerance to DNA.
D000818:Animals; D001323:Autoantibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000276:immunology*; D002250:Carbon Radioisotopes; D002482:Cellulose; D003520:Cyclophosphamide / Q000627:therapeutic use; D004247:DNA / Q000302:isolation & purification / Q000627:therapeutic use*; D005374:Filtration; D005455:Fluorescent Antibody Technique; D006462:Hemolytic Plaque Technique; D007108:Immune Tolerance; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000032:analysis; D007158:Immunologic Techniques; D007668:Kidney / Q000276:immunology; D008239:Lysine / Q000378:metabolism; D008567:Membranes, Artificial; D051379:Mice; D009691:Nucleic Acid Denaturation; D013154:Spleen / Q000166:cytology; D013950:Thymus Gland / Q000032:analysis
D001323:Autoantibodies; D002250:Carbon Radioisotopes; D007074:Immunoglobulin G; D008567:Membranes, Artificial; D003520:Cyclophosphamide; D002482:Cellulose; D004247:DNA; D008239:Lysine